Canada: Changes To Bureau Enforcement Policies Signal New Aggressive Stance

Canada's Competition Bureau (Bureau) today announced substantial revisions to their immunity and leniency policies' FAQs.  While the fundamental features of the programs do not change, new elements have been added signalling a more aggressive enforcement approach that could influence the decision to seek immunity or leniency in Canada.

Immunity FAQs

As with other antitrust regulators, Canada has maintained an immunity policy offering amnesty for first-in applicants disclosing antitrust conspiracy offences since 2000. The program has been tremendously successful in generating inquiry leads and a series of successful resolutions of cartel cases.  This most recent revision of the FAQs represents a substantial "tuning-up" of enforcement policies, aimed at ensuring that Canada will be among the more top-of-mind agencies for global cartel enforcement.  The most notable features of these revisions are as follows:

  • Prosecution for both direct and indirect cartelized sales into Canada. This is consistent with the Bureau's view that parties involved in cartels having only indirect sales into Canada are subject to prosecution and thus should apply for immunity under the policy;
  • A marker is now available for "aiding or abetting" competition offences. Only a single marker will be granted for each offence (whether that marker is for a substantive offence or "aiding/abetting");
  • No markers for offences of obstruction or destruction of records;
  • There is a new and more aggressive approach to making follow-up proffers and ensuring complete cooperation by applicants:
    • The Bureau will not disclose the applicant's identity to other enforcement agencies but will expect an "immediate" waiver permitting both substantive and procedural communications with other agencies where the applicant has made similar applications in other jurisdictions;
    • Markers will lapse after a 30-day period if the applicant fails to provide its proffer and the Bureau will not notify an applicant pending the expiry date;
    • Applicants unable to meet the 30-day proffer deadline must be prepared to offer information on the status of internal investigations and a work plan for completing the proffer;
    • The Bureau will not accept delays because of complications arising in other jurisdictions or because counsel may not be available;
    • All proffers are made on a "without prejudice" basis but the applicant is required to outline all supporting evidence and witnesses that it can provide by way of cooperation such that the Bureau will have "a clear appreciation of the evidence each witness...can provide";
    • The proffer should also include specifics of any evidence, destruction or attempts to obstruct the investigation; significant departures from this policy will result in automatic lapsing of the immunity marker;
    • If the applicant's proffer does not sufficiently disclose an offence the Bureau may request the applicant withdraw its marker or may cancel it following a 14 -day notice period;
    • The Bureau will typically require full disclosure within a 6-month timeline; violations of this may be considered to be a breach of the immunity agreement;
    • As to cooperation of current and former employees, corporate applicants are required to take "all lawful measures" to secure such cooperation, which may extend to agents or former directors, officers or employees covered by the agreement; generally, witnesses must travel to Canada for Bureau interviews;
    • Witness interviews may be requested before finalization of the immunity agreement; if the witness refuses to provide cooperation, the Bureau may recommend that that witness be "carved out" from the agreement and face prosecution;
    • Applicants must  provide information updates to the Bureau;
    • As to disclosure of previous offences, the revised policy requires disclosure of criminal offences under the Competition Act of which the applicant is aware and each applicant will be expected to exercise reasonable due diligence in determining such issues; disclosure of criminal offences affecting the credibility of individual witnesses is also expected;
    • Significantly, the disclosure process is said to be conducted on a "without prejudice" basis and neither the Bureau nor the Public Prosecution Service will use the information against the applicant or its individuals, unless there is a failure to comply with terms and conditions of the immunity agreement;
    • Offences uncovered after the signing of an immunity agreement are to be brought to the Bureau's attention; where late disclosure is made, the Bureau may recommend increased penalties;
    • An immunity applicant is required to give notice to the Bureau of any required public disclosure and must also disclose third parties to whom its application has been disclosed; violations of this policy may lead to expulsion from the immunity program;
    • Applicants are also required to keep the Bureau apprised of the general status of any civil proceedings and notify the Bureau of its intention to cooperate with civil litigants;
    • As to joint defence arrangements, the Bureau states that these must be subordinate to the applicant's commitment under the immunity program;
  • Applicants should consult with the Bureau about possible inadvertent disclosure of the immunity application or other concerns about confidentiality;
  • Coercive disqualifying conduct (which may be express or implied) is defined as requiring "clear evidence" and that the party "pressured unwilling participants to be involved in the offence";
  • In circumstances where an applicant may be eligible for "immunity plus" (in an non-immunity situation for one product but immunity on another) the Bureau will typically recommend an additional 5-10% on top of its leniency discount for the non-immunized product (typically 50%) based on a number of indicated factors;
  • The Bureau will support sealing orders to keep identities and other details of the applicant confidential, unless a court orders otherwise;
  • The Bureau will not commence civil proceedings against an applicant on substantially the same facts forming the basis for the immunity application.

Leniency Program FAQs

The Bureau's leniency program was initiated in 2010 and applies to parties that have not sought or obtained immunity in relation to the particular product or service under inquiry.  As second-in or later entities, leniency applicants accepted under this program are expected to plead guilty under a formal plea agreement and file admissions as to facts.  Many of the revisions to the Leniency Policy FAQs are identical to the Immunity provisions, including time limit restrictions and possible extensions, disclosure and co-operation arrangements, and the types of information that will be required.  Leniency applicants can apply whether they have direct or indirect sales into Canada. 

Significant leniency policy changes are:

  • Potential legal defences must be raised with the Bureau as soon as possible in order that the Bureau may assess its position; if the Bureau nevertheless concludes that an offence has been established, it is for the applicant to decide whether or not to pursue its leniency application;
  • As with the immunity program, all disclosures to the Bureau are said to be on a "without prejudice" basis;
  • As to fine calculation, the FAQs explain the Bureau's "20% of commerce" proxy fine calculation guideline and indicate that discounts up to 50% (first-in applicant) may be given to applicants;
  • Where the 20% commerce figure is greater than the statutory maximum ($25,000,000) the Bureau will adopt the maximum fine as a starting point;
  • In the case of market allocation agreements where there is no commerce in Canada, fine calculations will be made on a case-by-case basis and the Bureau will consider volumes of commerce covered by any relevant agreement or arrangement; sales to Canada will not be a governing feature;
  • For bid-rigging cases, fines will be calculated on the basis of the total volume of commerce covered by relevant agreements or arrangements;
  • Where indirect sales are concerned, the Bureau will "work with" an applicant to develop a methodology to estimate affected volumes of commerce and may limit their calculation to the value of the relevant input into the end product;
  • In cases where penalties are imposed in other jurisdictions, the Bureau may consider on a case-by-case basis whether penalties imposed elsewhere are adequate to address Canadian economic harm;
  • If an applicant has evidence that an overcharge was less than the Bureau's 20% proxy figure, the Bureau will consider such "readily accessible, compelling and evidence not requiring modelling" in its calculations;
  • As to charges for individuals, first-in leniency applicants will receive a complete exemption, while second-in and subsequent applicants will be considered on a case-by-case basis, based on a variety of factors;
  • The Bureau makes clear that non-prosecution arrangements "...are not available" under the leniency program;
  • Where an applicant is unable to pay a fine, the Bureau states that it will "critically assess" any evidence as to inability provided by the applicant; such evidence must be complete and explicit and may involve the Bureau's using an independent third-party expert to review such evidence;
  • After entering into a plea agreement, the applicant is subject to the same full and complete disclosure requirements as under the immunity program;
  • As with the immunity program, non-cooperating witnesses may be subject to carve-out from the plea agreement and face prosecution;
  • A plea agreement may be revoked where an applicant has not met the agreement's terms, although such revocation is made subject to a 14-day notice provision, in order to enable the applicant to remedy its failure;
  • Unless there are "compelling reasons", the Bureau will not recommend any delay in filing an indictment; specifically, delays will not be accepted because the party does not want to be the first-in-line to plead guilty;
  • As with the immunity policy, similar considerations will apply on issues of confidentiality in relation to other agencies, potential reporting requirements in other jurisdictions, and arrangements for cooperation to civil plaintiffs.

These changes to the FAQs represent an enhanced enforcement posture by the Bureau, with a clear indication of higher expectations for both immunity and leniency applicants for early cooperation and ongoing disclosure. As well, the Bureau indicates that it will seek to enforce its prosecution policy in cases where there may only be indirect sales to Canada, or for market allocation or bid-rigging agreements where the applicant may have no commerce in Canada.  These changes highlight the need for parties contemplating seeking immunity or leniency in Canada to seek the advice of expert counsel familiar with Bureau and Public Prosecution Service of Canada prosecution policies.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
Blake, Cassels & Graydon LLP
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Blake, Cassels & Graydon LLP
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions